This website uses cookies to enhance the user experience.
||
S

SKULSTAD AS816 508 312

Limited company
Grønnestølslien 38 5073 BERGEN, Norge

SKULSTAD AS

Operating
Medisinsk verksemd og investeringer i andre selskaper.

Organization

Chairman of the board
Years since formation
10 years
since Jan 5, 2016
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
30,000
1 share class
Total number of shareholders
1
person

Financials

Total operating income 2025
1,372,409
NOK
Annual total result 2025
222,432
NOK
Total equity 2025
4,655,414
NOK
Last update: Jun 9, 2026

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Chairman-

Others

NameRoleShares
A
AIDER AS
Accountant-

Top 10 individual shareholders

NameRoleShares
-
100 %
directly
Last update: Oct 1, 2025

Ownership

Company shareholders

NameShare classTotal number of sharesShare
Ordinary shares
30,000
100 %

Shares owned by the SKULSTAD AS

NameShare classTotal number of sharesShare
B
BALANCIAL AS
Ordinary shares
111,300
0.23 %
L
LIFECARE ASA
NO0013355859
20,711
0.13 %
L
LYTIX BIOPHARMA ASA
NO0010405780
41,590
0.06 %
A
AMICOAT AS
NO0010799679
13,557
0.04 %
P
PHARMA HOLDINGS AS
NO0010797350
71
< 0.01 %
P
PHARMASUM THERAPEUTICS AS
Ordinary shares
335
< 0.01 %
S
SOFTOX SOLUTIONS AS
NO0010811961
2,550
< 0.01 %
Last update: Jun 2, 2025

Financials

in NOK

Summary

Year20252024202320222021
Total operating income
1,372,409
1,689,809
1,849,726
1,806,297
1,764,172
Annual Total Result
222,432
-286,102
1,353,298
-103,787
1,240,205
Total assets
5,027,671
4,818,254
5,181,577
3,883,036
4,100,318
Total liabilities
372,257
385,271
362,493
317,249
430,744
Total equity
4,655,414
4,432,983
4,819,084
3,565,786
3,669,574

P&L

Year20252024202320222021
Total operating income
1,372,409
1,689,809
1,849,726
1,806,297
1,764,172
Total operating costs
1,162,848
1,164,464
1,108,309
1,229,409
189,581
Operating result
209,560
525,345
741,417
576,888
1,574,591
Financial income/costs
84,225
-645,501
774,168
-556,459
14,970
Profit before tax
293,786
-120,156
1,515,585
20,429
1,589,561
Total tax & extraordinary income/cost
71,354
165,946
162,287
124,216
349,356
Annual Total Result
222,432
-286,102
1,353,298
-103,787
1,240,205

Balance overview

Year20252024202320222021
Total fixed assets
52,501
303,269
253,269
261,965
253,269
Total current assets
4,975,170
4,514,985
4,928,308
3,621,071
3,847,049
Total assets
5,027,671
4,818,254
5,181,577
3,883,036
4,100,318
Short term debt
306,050
342,324
362,493
317,249
430,058
Long term debt
66,207
42,947
0
0
686
Total liabilities
372,257
385,271
362,493
317,249
430,744
Contributed capital
30,000
30,000
30,000
30,000
30,000
Retained earnings
4,625,414
4,402,983
4,789,084
3,535,786
3,639,574
Total equity
4,655,414
4,432,983
4,819,084
3,565,786
3,669,574
Total equity and liabilities
5,027,671
4,818,254
5,181,577
3,883,036
4,100,318

Classification

21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises